指南与共识湿疹皮炎与荨麻疹

湿疹应用程序与临床指南的符合性系统评估

Eczema apps conformance with clinical guidelines: a systematic assessment of functions, tools and content.
指南 / 共识 · Br J Dermatol · 2019-07-15

结果显示34%(28/82)的应用提供误导性信息,仅15%和16%分别提供指南支持的药物与非药物疗法信息,无一款应用符合全部标准。

要点

  • 湿疹应用普遍与临床指南不符,34%提供误导性信息
  • 仅少数应用提供指南支持的药物或非药物疗法信息
  • 尚无应用完全符合教育信息、追踪功能或健康信息原则的全部标准

核心结论

  • 湿疹自我管理应用尚未达到其潜力,质量差异大,亟需建立应用质量保障机制并为临床医生提供选择指导。
  • 多数应用与指南信息不符,对循证自我管理支持不足。

研究设计与样本

  • 纳入英文、中文和西班牙文的湿疹自我管理智能手机应用,共评估98款应用。
  • 评估领域包括湿疹特异性教育信息的一致性与全面性、追踪功能的质量与全面性、健康信息最佳实践原则的依从性。

主要发现

  • 98款应用中,82款(84%)提供教育信息,38款(39%)提供追踪功能,13款(13%)两者兼具。
  • 34%(28/82)的应用提供误导性信息,尤其涉及湿疹治疗和疾病进展。
  • 仅15%(12/82)提供国际指南支持的药物治疗信息,16%(13/82)提供非药物治疗信息。
  • 38款具追踪功能的应用中,82%(31/38)测量特定症状、疾病严重度或当前皮肤状况,89%(34/38)帮助记录用药包括外用制剂,34%(13/38)记录环境或饮食过敏原。
  • 无一款应用符合教育信息、追踪功能或健康信息原则的全部标准。

关键数值与推荐

  • 教育信息方面:34%(28/82)提供误导性信息;15%(12/82)提供指南支持的药物治疗信息;16%(13/82)提供指南支持的非药物治疗信息。
  • 追踪功能方面:82%(31/38)测量症状、严重度或皮肤状况;89%(34/38)记录用药;34%(13/38)记录环境或饮食过敏原。
  • 符合性判定:无应用符合全部评估标准。

临床怎么用

  • 临床医生应了解湿疹应用质量参差,谨慎向患者和照护者推荐应用。
  • 选择应用时应优先考察其教育信息是否符合国际湿疹指南及是否具备循证追踪功能。
  • 需推动建立健康应用质量保障机制以辅助个体化推荐。

局限性

  • 评估仅覆盖英文、中文和西班牙文应用,未涵盖其他语言应用。
  • 摘要未报告评估者一致性、评分细则权重等细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Eczema is a prevalent complex skin condition requiring active disease monitoring and personalized education. No studies have assessed the quality of apps that aim to support eczema self-management. OBJECTIVES: To evaluate the quality and comprehensiveness of English, Chinese and Spanish self-management eczema smartphone apps for patients and/or their caregivers. METHODS: A systematic assessment of eczema apps from July 2018 to November 2018. The assessment criteria were based on conformance with international eczema guidelines. The following domains were assessed: consistency and comprehensiveness of eczema-specific educational information; quality and comprehensiveness of eczema-specific tracking functions; compliance with health information best practice principles. RESULTS: In total, 98 apps were assessed: 82 (84%) provided educational information; 38 (39%) tracking functions; and 13 (13%) both. We found that 34% (28/82) of apps provided misleading information, particularly regarding aspects of treatment and disease progression of eczema. Only 15% (12/82) provided international guideline supported information on pharmacological therapies and 16% (13/82) on nonpharmacological therapies. Among 38 apps with a tracking function, 82% (31/38) measured specific symptoms, disease severity or current skin condition and 89% (34/38) helped users to record medication usage including application of topicals. Environmental or dietary allergens were recorded by 34% (13/38). None of the included apps complied with all criteria for educational information, tracking functions or health information principles. CONCLUSIONS: Eczema apps have not yet reached their potential. The large variance in quality of eczema apps highlights the need for quality assurance mechanisms for health apps and guidance for clinicians that would enable them to make personalized recommendations for patients and caregivers. What's already known about this topic? There is limited information about the quality of eczema self-management smartphone apps on the global market. What does this study add? This systematic assessment evaluated all English, Chinese and Spanish language apps that support eczema self-management. The majority did not conform with information in guidelines and insufficiently support evidence-based self-management. The large variance in the quality of eczema apps highlights the need for mechanisms to ensure app quality and to guide personalized app selection for patients, caregivers and doctors.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. van Galen LS, Xu X, Koh MJA, et al. Eczema apps conformance with clinical guidelines: a systematic assessment of functions, tools and content. Br J Dermatol. 2019. PMID: 31179535. doi:10.1111/bjd.18152

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。